NanoHive Medical Revenue and Competitors
Estimated Revenue & Valuation
- NanoHive Medical's total funding is $11M.
Employee Data
- NanoHive Medical has 18 Employees.
- NanoHive Medical grew their employee count by -5% last year.
NanoHive Medical's People
Name | Title | Email/Phone |
---|---|---|
1 | President & CEO | Reveal Email/Phone |
2 | Chief Technology Officer | Reveal Email/Phone |
3 | Regional VP - Northeast | Reveal Email/Phone |
4 | Regional VP Sales | Reveal Email/Phone |
5 | Area VP- West | Reveal Email/Phone |
6 | Regional VP Sales- Central | Reveal Email/Phone |
7 | VP Marketing | Reveal Email/Phone |
8 | Director Sales Operations | Reveal Email/Phone |
9 | Quality & Regulatory Manager | Reveal Email/Phone |
10 | Sales and Marketing Program Manager | Reveal Email/Phone |
NanoHive Medical Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | N/A | 242 | 28% | N/A | N/A |
#2 | $7.5M | 14 | 0% | N/A | N/A |
#3 | N/A | 10 | 25% | N/A | N/A |
#4 | N/A | 4 | -20% | N/A | N/A |
#5 | N/A | 18 | 20% | $28.9M | N/A |
#6 | $7.5M | 99 | 3% | N/A | N/A |
#7 | $7.5M | 72 | 33% | N/A | N/A |
#8 | N/A | 17 | 55% | N/A | N/A |
#9 | N/A | 5 | 67% | N/A | N/A |
#10 | N/A | 10 | 0% | N/A | N/A |
What Is NanoHive Medical?
NanoHive Medical (formerly HD LifeSciences) created the proprietary, biomimetic Soft Titanium technology, which clearly distinguishes their products in the $1.9B spinal interbody fusion device market. The Hive™ portfolio of interbody fusion devices provides surgeons and their patients with the ideal features that lead to consistently strong fusion constructs and efficacious clinical experiences.
keywords:N/A$11M
Total Funding
18
Number of Employees
N/A
Revenue (est)
-5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.5M | 18 | 13% | N/A |
#2 | $2.4M | 18 | 6% | $2M |
#3 | $1.6M | 19 | 6% | N/A |
#4 | N/A | 19 | 19% | $130M |
#5 | $4.9M | 20 | 0% | N/A |